Healthcare Services

Preclinical Imaging Market Developments and Growth Opportunities Across 2026–2030

April 6, 2026April 6, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Expected For The Preclinical Imaging Market At The End Of The 2026–2030 Forecast Period?

The preclinical imaging market size has experienced robust expansion over recent years. This market is projected to expand from $3.69 billion in 2025 to $3.93 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.7%. Historically, this expansion has been driven by factors such as the greater utilization of animal models in biomedical research, the enlargement of oncology and neurology research, the increasing acceptance of non-invasive imaging methods, a rise in preclinical drug testing efforts, and the accessibility of sophisticated imaging reagents.

The preclinical imaging market is anticipated to experience substantial expansion in the coming years, projected to reach $5.18 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.1%. This projected growth is driven by several factors, including heightened demand for real-time disease visualization, increased investments in translational research, the broadening of precision medicine studies, the expanding application of AI-assisted image analysis, and the greater implementation of advanced contrast agents. Concurrently, major trends expected during this period involve the growing embrace of multi-modal imaging platforms, the increased utilization of high-resolution imaging systems, the deeper integration of imaging with data analytics, the enlargement of longitudinal disease monitoring studies, and a sharpened emphasis on translational imaging accuracy.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12393&type=smp

Which Market Drivers Are Supporting The Expansion Of The Preclinical Imaging Market?

The rising incidence of chronic diseases is projected to drive the growth of the preclinical imaging market in the future. Chronic diseases are long-term health conditions that persist for an extended duration, usually three months or longer. These conditions often require continuous medical management and can significantly impact a person’s quality of life. Preclinical imaging tools are employed to identify chronic diseases through the visualization of bone structure and lung function. They are also used to investigate chronic diseases, allowing researchers to visualize disease progression and enhance understanding. For example, in February 2024, according to the World Health Organization (WHO), a Switzerland-based agency focused on international public health, non-communicable diseases (NCDs) are responsible for 75% (three-quarters) of all deaths worldwide. Consequently, the increasing prevalence of chronic diseases is propelling the expansion of the preclinical imaging market.

What Segment Types Make Up The Preclinical Imaging Market?

The preclinical imaging market covered in this report is segmented –

1) By Modality: Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-Magnetic Resonance Imaging Systems, Micro-Ultrasound Systems, Micro-Computed Tomography Systems, Preclinical Photoacoustic Imaging Systems, Preclinical Magnetic Particle Imaging (MPI) Systems

2) By Reagents: Preclinical Optical Imaging Reagents, Preclinical Nuclear Imaging Reagents, Preclinical MRI Contrast Agents, Preclinical Ultrasound Contrast Agents, Preclinical CT Contrast Agents

3) By End User: Hospital, Diagnostics Center, Other End-User

Subsegments:

1) By Optical Imaging Systems: Bioluminescence Imaging, Fluorescence Imaging

2) By Preclinical Nuclear Imaging Systems: Positron Emission Tomography (PET), Single-Photon Emission Computed Tomography (SPECT)

3) By Micro-Magnetic Resonance Imaging (Micro-MRI) Systems: High-Resolution Micro-MRI Systems, Functional Micro-MRI Systems

4) By Micro-Ultrasound Systems: High-Frequency Ultrasound Imaging, Real-Time Micro-Ultrasound Systems

5) By Micro-Computed Tomography (Micro-CT) Systems: In Vivo Micro-CT Systems, Ex Vivo Micro-CT Systems

6) By Preclinical Photoacoustic Imaging Systems: Multi-Wavelength Photoacoustic Imaging, Hybrid Photoacoustic Imaging Systems

7) By Preclinical Magnetic Particle Imaging (MPI) Systems: MPI For Cell Tracking, MPI For Vascular Imaging

What Trends Are Affecting The Expansion Of The Preclinical Imaging Market?

Leading companies within the preclinical imaging market are increasingly focusing on introducing advanced imaging systems to gain a competitive advantage. Next-generation imaging systems denote sophisticated and innovative technologies that extend beyond current capabilities, incorporating cutting-edge features. For example, in September 2023, Revvity Inc., a US-based biotechnology company, released next-generation imaging systems developed to foster innovation across various applications in preclinical research. The new products include the next-generation IVIS Spectrum 2 and the IVIS SpectrumCT 2 imaging systems, the Quantum GX3 microCT imaging solution, and a system that smoothly combines 2D optical and full 3D imaging. These imaging systems offer improved image-based functionalities and are engineered to optimize the imaging workflow.

Who Are The Key Players Driving Competition In The Preclinical Imaging Market?

Major companies operating in the preclinical imaging market are Thermo Fisher Scientific Inc, FUJIFILM Visualsonics Inc, Agilent Technologies Inc, PerkinElmer Inc, Bruker Corporation, Miltenyi Biotech, Sofie Biosciences Inc, Ion Beam Applications SA, Piramal Enterprises Ltd, LI COR Biosciences Inc, Aspect Imaging Ltd, Capintec Inc, Spectral Instruments Inc, Mediso Ltd, MR Solutions Ltd, Biospace Lab SA, Scintica Instrumentation Inc, Trifoil Imaging, Bioscan Inc, Inviscan SAS, Kubtec X Ray, MILabs BV, SCANCO Medical AG, Fujifilm Holdings Corporation

Read the full preclinical imaging market report here:

https://www.thebusinessresearchcompany.com/report/preclinical-imaging-global-market-report

How Is The Preclinical Imaging Market Distributed Across Key Geographic Regions?

North America was the largest region in the preclinical imaging market in 2025. The regions covered in the preclinical imaging market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Preclinical Imaging Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12393&type=smp

Browse Through More Reports Similar to the Global Preclinical Imaging Market 2026, By The Business Research Company

Healthcare Cro Services Global Market Report

https://www.thebusinessresearchcompany.com/report/healthcare-cro-services-global-market-report

Crm Bpo Global Market Report

https://www.thebusinessresearchcompany.com/report/crm-bpo-global-market-report

Veterinary Cro And Cdmo Global Market Report

https://www.thebusinessresearchcompany.com/report/veterinary-cro-and-cdmo-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795